Next Article in Journal
Leptin and Physical Activity in Adult Patients with Anorexia Nervosa: Failure to Demonstrate a Simple Linear Association
Next Article in Special Issue
Elucidating the Skin Delivery of Aglycone and Glycoside Flavonoids: How the Structures Affect Cutaneous Absorption
Previous Article in Journal
A New Proposal for the Pathogenic Mechanism of Non-Coeliac/Non-Allergic Gluten/Wheat Sensitivity: Piecing Together the Puzzle of Recent Scientific Evidence
Previous Article in Special Issue
Recovery Effects of Oral Administration of Glucosylceramide and Beet Extract on Skin Barrier Destruction by UVB in Hairless Mice
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
Journals
Nutrients
Volume 9
Issue 11
10.3390/nu9111209
nutrients-logo
Submit to this Journal Review for this Journal Edit a Special Issue
► Article Menu

Article Menu

share announcement question_answer thumb_up
...
textsms
...
Article

Effect of Orally Administered Collagen Peptides from Bovine Bone on Skin Aging in Chronologically Aged Mice

by
Hongdong Song
1,
Siqi Zhang
1,
Ling Zhang
1 and
Bo Li
1,2,*
1
Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China
2
Beijing Higher Institution Engineering Research Center of Animal Product, Beijing 100083, China
*
Author to whom correspondence should be addressed.
Nutrients 2017, 9(11), 1209; https://doi.org/10.3390/nu9111209
Received: 19 September 2017 / Revised: 29 October 2017 / Accepted: 31 October 2017 / Published: 3 November 2017
(This article belongs to the Special Issue Nutraceuticals and the Skin: Roles in Health and Disease)
Download PDF
Browse Figures

Abstract

Collagen peptides (CPs) have demonstrated to exert beneficial effects on skin photoaging. However, little has been done to evaluate their effects on chronologically aged skin. Here, the effects of CPs from bovine bone on skin aging were investigated in chronologically aged mice. 13-month-old female Kunming mice were administered with CPs from bovine bone (200, 400 and 800 mg/kg body weight/day) or proline (400 mg/kg body weight/day) for 8 weeks. Mice body weight, spleen index (SI) and thymus index (TI), degree of skin laxity (DSL), skin components, skin histology and antioxidant indicators were analyzed. Ingestion of CPs or proline had no effect on mice skin moisture and hyaluronic acid content, but it significantly improved the skin laxity, repaired collagen fibers, increased collagen content and normalized the ratio of type I to type III collagen in chronologically aged skin. CPs prepared by Alcalase performed better than CPs prepared by collagenase. Furthermore, CPs intake also significantly improved the antioxidative enzyme activities in skin. These results indicate that oral administration of CPs from bovine bone or proline can improve the laxity of chronologically aged skin by changing skin collagen quantitatively and qualitatively, and highlight their potential application as functional foods to combat skin aging in chronologically aged process.
Keywords: collagen peptides; bovine bone; proline; skin aging; chronologically aged mice; antioxidative enzymes collagen peptides; bovine bone; proline; skin aging; chronologically aged mice; antioxidative enzymes

1. Introduction

The impact of aging on the appearance and function of skin has received increasing attention in recent decades. It is widely accepted that skin aging is distinguished into chronological skin aging and skin photoaging [1]. Skin photoaging is caused by solar radiation and it is common in sunlight-exposed skin, especially in the face [2]. Therefore, skin photoaging could be prevented or decreased by photo-protection. The common clinical signs of photoaged skin include deep and coarse wrinkles, dryness, sallowness and laxity [2,3]. In contrast, chronological skin aging is caused by passage of time and it takes place all the time in whole-body skin, including facial skin. Chronologically aged skin is characterized by fine wrinkling and laxity [3]. Chronological skin aging accounts for a great part of skin aging and it is more common than skin photoaging in dark skinned individuals and females [2]. A youthful appearance is considered to play an important role in keeping self-esteem and social relations [4]. Therefore, there is increasing demand for anti-aging interventions to delay or even reverse signs of skin aging.
The use of diet supplements to improve the appearance and function of aged skin has received growing attention. Many dietary components, such as polyphenols [5], vitamins [6], fatty acids [7], trace minerals [8] and proteins [9], have reported to exert beneficial effects on aged skin and have been used as nutraceuticals or functional foods in many counties and regions. Recently, researchers have paid much attention to protein hydrolysates as potential dietary supplements. Collagen is the main structural protein of the different connective tissues, such as skin, bone, cartilage and tendons, and has been widely used in the medicine and food industries. Collagen peptides (CPs) are the enzymolysis product of collagen or gelatin and they are used as important active components because of their various bioactivities, high bioavailability and good biocompatibility [10,11,12]. Several studies have demonstrated the beneficial effects of CPs ingestion on skin photoaging. Oral administration of CPs from fish skin had obvious protective effects on photoaging skin, including improving moisture retention ability, repairing the endogenous collagen and elastin protein fibers [13,14,15]. In addition, clinical trials have also demonstrated that the beneficial effects of CPs intake on facial skin, including improving facial skin elasticity, reduce skin dryness and wrinkles, and increase the collagen content of the skin dermis [16,17]. However, little work was performed to evaluate the effects of CPs intake on chronologically aged skin.
Bovine bone is the main by-products in the bovine processing industry and has been widely used as raw material to obtain high-quality gelatin [18]. Although there are some concerns with mad cow disease in Europe and the United States, bovine bone is still one of the most abundant sources of gelatin and accounts for 23.1% of the gelatin production [19]. Therefore, bovine bone is an abundant and high-quality raw material used to prepare CPs. The biological effect of CPs from bovine bone is mainly concentrated on its beneficial effect on bone metabolism, including inhibition of bone loss and improvement of osteoarthritis [20,21]. However, there is limited knowledge about the effect of CPs from bovine bone on skin aging. Therefore, preparing CPs from bovine bone and further evaluating its effect on skin aging is a good way to utilize the by-products for an economical and environmental advantage.
The functional activities of protein-derived hydrolysates or peptides are greatly impacted by their molecular structure and weight, which are highly affected by their processing conditions and especially enzyme specificity [15,22]. Alcalase is a common protease and widely used to prepare protein hydrolysate or peptides. It is a typical endoprotease and preferentially cleaves sites containing hydrophobic residues, such as Ala, Leu, Val and Phe. Bacterial collagenase is a protease that hydrolysates collagen. It has a preference for X-Gly (X is usually a neutral amino acid) bond of the -Gly-Pro-X-Gly-Pro-X- repeating sequence in the collagen molecule [23,24]. Collagenase has a great promise in collagen processing industry. Considering enzyme specificity, the molecular structure or sequences of peptides produced by these two enzymes may be different, which may greatly impact their effects on chronologically aged skin.
The objective of the present study is to investigate the effects of CPs from bovine bone on skin aging based on the chronologically aged model. Bovine bone was employed as a raw material to prepare different CPs using Alcalase and collagenase. Then, the effects of CPs from bovine bone on chronologically aged skin were investigated in chronologically aged mice by analyzing the skin histology, skin components and antioxidative indicators. The results showed that oral administration of CPs from bovine bone has beneficial effects on chronologically aged skin by improving the skin laxity, but it had no on moisture retention of skin. CPs prepared by Alcalase performed better than CPs prepared by collagenase.

2. Materials and Methods

2.1. Materials and Chemicals

Alcalase was purchased from Novozymes (Beijing, China). Proline (food grade) and bacterial collagenase were purchased from Sigma-Aldrich (St. Louis, MO, USA). The bicinchoninic acid (BCA) protein assay kit was purchased from Beijing Solarbio Science and Technology Co., Ltd. (Beijing, China). Commercial kits used for determining hydroxyproline (Hyp), type I and type III collagen, hyaluronic acid (HA), superoxide dismutase (SOD), catalase (CAT), and malondialdehyde (MDA) were purchased from Jiancheng Inst. of Biotechnology (Nanjing, China). All other chemicals used in the study were of analytical grade or better.

2.2. Collagen Peptides (CPs) Preparation

Gelatin was extracted from bovine bone with hot water. Briefly, the bovine bone was treated in boiling water for 6 h, followed by removing bone using gauze filter. The filtrate was cooled, defatted and centrifuged at 4500× g for 15 min with a refrigerated centrifuge (TGL-185, Pingfan Co., Ltd., Changsha, China). After centrifugation, the upper soluble fractions were collected and freeze-dried to obtain the gelatin. The gelatin was enzymatically hydrolyzed by the Alcalase at pH 8.0 for 4.0 h to obtain collagen peptides (named ACP), and the collagenase at pH 7.5 for 3.0 h to obtain collagen peptides (named CCP). Finally, the hydrolysates were dialyzed to discard salt and free amino acids, freeze-dried and stored at −80 °C until use.

2.3. Molecular Weight Distribution

The molecular weight distribution of CPs was measured using a Shimadzu LC-15C high performance liquid chromatography (HPLC) system (Shimadzu, Tokyo, Japan) equipped with a TSK gel G2000 SWXL column (7.8 × 300 mm, Tosoh, Tokyo, Japan). Samples were loaded onto the column and eluted with 45% (v/v) acetonitrile containing 0.1% (v/v) trifluoroacetic acid at a flow rate of 0.5 mL/min and monitored at 214 nm at room temperature. A molecular weight calibration curve (y = −0.1881x + 6.5867, y: log MW, x: time, R2 = 0.9954) was obtained from the average retention times of the following standards: Gly–Ser (146 Da), Asn–Cys–Ser (322 Da), Trp–Pro–Trp–Trp (674 Da), bacitracin (1423 Da) and aprotinin (6512 Da) [15].

2.4. Amino Acid Composition

The samples were hydrolyzed in 6.0 M HCl at 110 °C for 24 h. After phenylisothiocyanate (PITC) derivatization reaction, the amino acid composition was analyzed by a Shimadzu LC-15C high performance liquid chromatography (HPLC) system (Shimadzu, Tokyo, Japan) equipped with a reverse Zorbax SB-C18 column (4.6 × 250 mm, Agilent, Santa Clara, CA, USA). The mobile phase consisted of (A) 10 mM phosphate buffer solution (pH 6.9) and (B) 100% acetonitrile and the flow rate was 1.0 mL/min. The gradient was programmed as follows: 0–5 min, 5–10% B; 5–25 min, 10–17% B; 25–45 min, 17–35% B; 45–48 min, 35–100% B; 48–50 min, 100% B; 50–58 min, 100–5% B; and 58–60 min, 5% B. The detection wavelength was set at 254 nm [15].

2.5. Animals, Diets, and Treatments

Animal experiments were carried out under the protocols approved by the Committee for Animal Research of Peking University and followed the Guide for the Care and Use of Laboratory Animals (NIH publication No. 86-23, revised 1996). The present experiment was approved by the Animal Experimental Welfare & Ethical Inspection Committee, the Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture (Beijing, China), and was performed in the Experimental Animal Center, Supervision and Testing Center for GMOs Food Safety, Ministry of Agriculture (SPF grade, Beijing, China).
Two-month-old (young mice, 28 ± 2 g, specific pathogen free (SPF) grade) and thirteen-month-old (old mice, 45 ± 5 g, SPF grade) female Kunming mice were purchased from Sibeifu (Beijing) Laboratory Animal Science and Technology Co., Ltd. (Beijing, China). The two-month-old mice were set as young controls (n = 10) and were given 0.2 mL normal saline. The thirteen-month-old mice were divided, based on body weight, into 6 groups (n = 10/group), including the model group and CPs treatment groups. The model group was given 0.2 mL normal saline; whereas the CPs treatment groups were given 0.2 mL ACP at doses of 200 (ACP-200), 400 (ACP-400) and 800 mg/kg body weight (ACP-800), respectively, and 0.2 mL CCP at a dose of 400 mg/kg body weight (ACP-400). In addition to free access to normal AIN-93M purified diet and water, each group was intragastrically administrated with 0.2 mL of normal saline or CPs once a day for eight weeks. After eight weeks, mice were sacrificed and samples were collected for further treatment and analysis.

2.6. Measurement of Degree of Skin Laxity (DSL)

During the period of this study, mice backs were epilated with 6% (w/w) sodium sulfide 2 days before measuring degree of skin laxity each time. Briefly, the dorsal skin, about 1 cm away from the tail root, was gently stretched by left hand with mice hind limbs off the table top slightly. Right hand controls mouse movement by pulling tail. The stretch length was measured immediately when mice were immobile. The DSL was defined as the following equation: DSL (mm) = stretch length of dorsal skin.

2.7. Measurement of Spleen Index (SI) and Thymus Index (TI)

The mice were weighed and sacrificed. Spleen and thymus were excised from the mice and weighed immediately. The spleen index (SI) and thymus index (TI) were calculated according to the following equation: SI or TI (mg/g) = (weight of spleen or thymus)/body weight.

2.8. Histological Analysis

After eight weeks, mice were sacrificed and dorsal skin samples were dissected out immediately. 4 skin samples (About 1 cm2) in each group were fixed in 4% buffered neutral formalin solution for 24 h, and embedded in paraffin. Serial sections (7 μm) were put onto silane-coated slides and stained with haematoxylin–eosin (HE). The stained sections were further analyzed using an optical microscope. 1 representative image of HE-stained dorsal skin section in each group was presented in part of results.

2.9. Measurement of Moisture Content

Mice backs were epilated with 6% (w/w) sodium sulfide 2 days before sacrificing mice. Dorsal skins were collected after mice were sacrifice and skin moisture was measured immediately. The moisture content of skin sample was determined according to GB/T5009.3-2010, a national standard of China for measuring moisture content. This method was employed to measure moisture content of skin in several previous reports [13,14]. Briefly, about 0.1 g of powdered skin sample was put into weighing bottle and dried in an oven at 105 °C for 4 h. The moisture content was calculated according to the following equation:
Moisture content = (m1 − m2)/(m1 − m3) × 100
m1, m2 and m3 is the weight of weighing bottle plus skin sample, weighting bottle plus dry finished skin sample and weighing bottle, respectively.

2.10. Determination of Hyaluronic Acid (HA) Content

About 0.1 g skin tissue was powdered in a liquid nitrogen bath and homogenized in pre-cooling saline. After centrifugation at 14,000× g for 15 min at 4 °C with a refrigerated centrifuge (TGL-185, Pingfan Co., Ltd., Changsha, China), the supernatant was collected to analyze the hyaluronic acid (HA) content using a commercial HA measurement kit (Nanjing Jiancheng Bio Inst., Nanjing, China).

2.11. Determination of Collagen Content

A commercial hydroxyproline assay kit (Nanjing Jiancheng Bio Inst., Nanjing, China) was used to analyze the Hyp content. Briefly, about 0.05 g skin tissue was totally hydrolyzed, oxidized and reacted with dimethyl-amino-benzaldehyde. The end product has a maximal absorption at 550 nm. The Hyp content in the skin was finally determined by comparison with the absorbance of the Hyp standard. The collagen content was calculated according to the Hyp content using a conversion factor of 8.00 [25].

2.12. Ratio of Type I to Type III Collagen

Commercial type I and type III collagen assay kits (Nanjing Jiancheng Bio Inst., Nanjing, China) were used to analyze the relative content of type I and type III collagen. The ratio of type I to type III collagen was calculated according to the following equation: ratio of type I to type III collagen = content of type I collagen/content of type I collagen.

2.13. Antioxidant Indicators Analysis

Skin tissue were powdered in a liquid nitrogen bath and homogenized with 9 weights of pre-cooling saline. Homogenate was centrifuged at 14,000× g for 15 min at 4 °C with a refrigerated centrifuge (TGL-185, Pingfan Co., Ltd., Changsha, China) to collect the supernatants. Total protein concentration was determined using a bicinchoninic acid (BCA) assay kit (Solarbio, Beijing, China). The SOD activity, CAT activity and malondialdehyde MDA content (expressed as MDA equivalents) were analyzed using the corresponding enzyme-linked immunosorbent assay (ELISA) kit (Nanjing Jiancheng Bio Inst., Nanjing, China) according to the manufacturer‘s instructions and the results were expressed in U/mg protein or nmol/mg protein.

2.14. Statistical Analysis

Results are expressed by the means ± standard deviation (SDs). Comparisons between two groups were analyzed by Student’s t-test. Differences between the means of the individual groups were analyzed using the analysis of variance (ANOVA) with Duncan’s multiple range tests. A difference was considered statistically significant when p < 0.05. All computations were performed with SPSS Statistics 19 (IBM, Chicago, IL, USA).

3. Results

3.1. Characterization of Collagen Peptides

Alcalase and collagenase (two optimized enzymes in our prior study) were used for producing different collagen peptides (named ACP and CCP, respectively). The molecular weight distributions of ACP and CCP are shown in Figure 1. ACP and CCP had a similar molecular weight distribution. Both ACP and CCP mainly consisted of peptides in molecular weight ranges of <500 Da (more than 50%), and the peptides of <1000 Da accounted for approximately 70% and 74%, respectively.
The amino acid compositions of ACP and CCP are shown in Table 1. ACP and CCP had similar amino acid compositions. Gly is the most dominant amino acid in ACP and CCP, which is consistent with the Gly-X-Y repeating sequence in the collagen macromolecule. In addition, ACP and CCP are also rich in Pro, Glu, Phe, Arg and Thr.

3.2. Degree of Skin Laxity

As summarized in Table 2, degree of skin laxity (DSL) of young (Y) group was increased during the experiment period but significantly lower than that of model group (old mice), which indicated that skin laxity was increased in an age-dependent manner. During the 8 weeks, the DSL of mice in CPs-treated groups (ACP and CCP groups) decreased over time compared with that in week 0. Significant differences in DSL were seen between ACP-400 group and time-matched model group at week 6 (p < 0.05), and the DSL of ACP-400 had no significant difference with that of young group. Furthermore, when the time of oral intake of ACP was as long as 8 weeks, the DSL of all ACP-fed groups decreased to the level of young group (p > 0.05), and some of groups (ACP-800 and CCP-400) were even better than the young group. Similarly, oral administration of proline at a dose of 400 mg/kg body weight also reduced the DSL with a significant difference observed compared with the time-matched model group at week 8 (p < 0.05).

3.3. Body Weight, Spleen Index (SI) and Thymus Index (TI)

The body weight of young group was increased during the experiment period, whereas that of model group remained stable (Table 3). Treatment with ACP (200, 400 and 800 mg/kg body weight), CCP and proline (400 mg/kg body weight) for 8 weeks caused no statistically significant differences in the body weight compared with the untreated model group. Furthermore, the SI and TI of ACP groups, CCP and proline groups also had no significant difference compared to that of the model group. The body weight and organ indices could be measured to preliminarily determine whether a sample or sample dose had obvious toxicological effects on the animal subjects [26]. There was no obvious atrophy, hyperplasia or swelling of spleen and thymus after CPs and proline intake. Based on these results, it was concluded that oral administration of CPs from bovine bone at doses of 200–800 mg/kg body weight, or proline at 400 mg/kg body weight for 8 weeks, had no obvious toxicological effects.

3.4. Skin Histology

The results of morphological examination of mice dorsal skin are illustrated in Figure 2. Skin collagen fibers in dermis were stained a light red with haematoxylin–eosin (HE). In the model group (old mice), lighter red and more space (green arrow) were observed in the dermis tissue than were those of the young group. There were thinner dermis and less sebaceous gland (red arrow) in the model group compared with the young group. After ACP and CCP intake, the space in the dermis tissue was decreased and the fibers appeared to be denser and more organized compared with the model group. Besides, the number of sebaceous gland was increased when treated by ACP, especially at dose of 800 mg/kg body weight. These results indicated that ACP improved the aged collagen fibers in skin dermis in a dose-dependent manner. Similarly, the sparse, fragmented, and disorganized fibers were also obviously improved and the number of sebaceous gland was greatly increased by the oral administration of proline at a dose of 400 mg/kg body weight for 8 weeks.

3.5. Skin Components

The results of skin moisture, hyaluronic acid (HA), collagen content and ratio of type I to type III collagen are shown in Figure 3A–D. Skin moisture content and ratio of type I to type III collagen in the model group (old mice) were significantly lower than that in the young group (all p < 0.05), indicating that skin moisture content and ratio of type I to type III collagen were decreased with age. Skin HA and collagen contents were also lower than that in the young group, although there was no significant difference observed compared with the model group. Ingestion of CPs (both ACP and CCP) and proline had no significant effect on skin moisture and HA contents compared with the model group. In contrast, oral administration of ACP (200, 400 and 800 mg/kg body weight) caused a dose-dependent increase in the collagen content, and there was a significant difference in the collagen content between the group receiving 800 mg/kg of ACP and the model group (p < 0.05). Ingestion of CCP at a dose of 400 mg/kg body weight also increased the collagen content in skin (p < 0.05 vs. the model group). However, proline intake at a dose of 400 mg/kg body weight had no significant effect on collagen content compared with the model group. A dose-dependent increase was also observed for ratio of type I to type III collagen in the ACP-fed groups, and there were significant differences between the groups receiving 400 and 800 mg/kg of ACP and the model group (all p < 0.05); whereas CCP ingestion at a dose of 400 mg/kg body weight had no significant effect on ratio of type I to type III collagen compared to the model group. Oral administration of proline also significantly increased ratio of type I to type III collagen in skin (p < 0.05 vs. the model group).

3.6. Antioxidant Indicators

The superoxide dismutase (SOD), catalase (CAT) and malondialdehyde (MDA) content in skin are shown in Table 4. The SOD and CAT activities in the M group were significantly lower in the skin compared to the Y group (p < 0.05); whereas the MDA level in the model group was higher than that in the young group (p < 0.05). Oral administration of CPs (both ACP and CCP) significantly increased the SOD and CAT activities and reduced the MDA level (all p < 0.05 vs. the model group). Besides, the increase of SOD and CAT activities and the decrease of MDA level in ACP-fed groups showed a dose-dependent manner. In contrast, proline ingestion had no obvious significant effect on these three antioxidant indicators.

4. Discussion

Skin aging is consisted of chronological aging and photoaging. There are some difference in clinical signs and underlying mechanisms for these two processes [27,28]. Collagen peptides (CPs) have been widely reported to exert beneficial effects on photoaging skin, but few studies was carried out to evaluate their effect on chronologically aged skin. In present study, 13-month-old Kunming mice, equivalent to 45 years old of human life [29], were employed to investigate the effect of CPs on chronologically aged skin. In several previous clinical trials, a daily dose of 2.5 g or 5 g of CPs has been employed in adult subjects, and these doses were considered to be safe [16,17,30]. According to the conversion of animal doses to human equivalent dose (HED) based on the body surface area (BSA) [31], about daily dose of 500 or 1000 mg/kg body weight could be used in mice. In addition, daily doses of 50–200 mg/kg body weight have also been used in several animal experiments [13,14,15]. Therefore, doses of 200, 400 and 800 mg/kg body weight/day were employed in the present study.
Skin laxity is a main feature of natural skin aging and is increased with age [32]. Therefore, skin laxity was dynamically evaluated by measuring the degree of skin laxity (DSL) to observe the effect of CPs intake on chronologically aged skin. An obvious beneficial effect was observed after 8 weeks of CPs intake. Therefore, mice were sacrificed and samples were collected for further treatment and analysis after 8 weeks. Unexpectedly, proline (abundant in collagen) ingestion also significantly improved skin laxity. These results provided guidance for the application of CPs or proline against chronological skin aging. The 8-week duration of CPs ingestion might be equivalent to several years old of human life in terms of life span. But it does not mean that the beneficial effects of CPs could be observed only after several years duration of CPs intake, because several studies have reported that significant beneficial effects of CPs on aging skin could be observed after 6 to 12 weeks in both clinical trials and animal experiments [13,14,15,16,17].
As the main component of the skin dermis, collagen has been reported to be beneficial in improving skin laxity and decreasing the appearance of wrinkles and its reduction in the quantity and quality is a major cause of laxity and wrinkles [33,34]. In the chronologically aged skin, dermal collagen fiber became sparse, fragmented and disorganized [35,36]. However, intake of CPs (both ACP and CCP) repaired collagen fibers and the fibers appeared to be denser and more organized compared to the aged skin. Collagen in skin mainly consists of type I and type III collagen. Collagen production and the ratio of type I to type III collagen is decreased gradually with age [14,28,37,38]. Type I collagen tend to form broader bundles of fibers, while type III collagen forms narrow bundles. A decrease in the diameter and number of the collagen bundles is correlated with the decrease in load and tensile strength reported in aging skin [38]. Oral administration of CPs increased the collagen content and ratio of type I to type III collagen in a dose-dependent manner, which suggested that CPs improved skin laxity by changing skin collagen quantitatively and qualitatively. In contrast, the skin moisture and hyaluronic acid (HA) were not affected by CPs ingestion. HA is a key molecule involved in skin moisture, because it has a unique capacity to bind and retain water molecules [39]. Taken together with the results of the current study, it was concluded that oral administration of CPs had beneficial effect on chronologically aged skin by improving skin laxity, but it had no influence on moisture retention of skin.
Interestedly, ingestion of proline also had beneficial effect on chronologically aged skin in terms of skin laxity, collagen content and ratio of type I to type III collagen. This result of in vivo study was consistent with that of a previous in vitro experiment which demonstrated that proline could increase the collagen synthesis of confluent fibroblasts, but it did not stimulate the proliferation of fibroblasts [40,41]. Watanabe-Kamiyama and coworkers have reported that proline could reach the skin after proline intake [42]. Therefore, we speculated that proline intake exerted beneficial effect on chronologically aged skin by increasing the collagen synthesis of skin fibroblasts.
It has been widely accepted that oxidative stress plays a critical role in initiating and driving the signaling events that result in skin aging. Study has reported that the production of reactive oxygen species (ROS) was increased in photoaged and chronologically aged skin [43]. In addition to directly attacking macromolecules, such as proteins, lipids, DNA and RNA, the excessive ROS also initiate several signaling pathways, including mitogen-activated protein kinases (MAPKs) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and further activate transcription factor activator protein-1 (AP-1) [44]. AP-1 induces collagen degradation by upregulating collagen-degraded enzymes such as matrix metalloprotease (MMP)-1, MMP-3 and MMP-9 and downregulating the biosynthesis of collagen. These changes in the skin lead to the phenotype of aged skin [45]. Therefore, antioxidants or free radical scavengers, such as ascorbic acid and polyphenols were reported to improve skin aging by scavenging excessive ROS. Normally, endogenous antioxidant enzymes are able to scavenge the excessive ROS to protect skin tissues from oxidative injuries. SOD and CAT are two antioxidant enzymes that inactivate superoxide anions and hydrogen peroxide, respectively. MDA is a product of lipid peroxidation and is usually quantified to estimate the lipid peroxidation extent induced by ROS. The SOD and CAT activities were decreased and MDA content was increased with age. However, CPs (ACP and CCP) intake could increase SOD and CAT activities and decrease MDA content, indicating that ingestion of collagen peptides from bovine bone had the ability to decrease ROS in skin. The decreased ROS in skin might help to increase the biosynthesis of collagen and decrease the collagen degradation by reducing the MMPs production. Indeed, several previous studies have reported that collagen hydrolysate ingestion could increases skin collagen expression and suppresses MMP-1 and MMP-2 [46,47]. In vitro study had demonstrated that ACP and CCP had high antioxidant capacity base on the hydroxyl radicals and ABTS + scavenging assays (data not shown). In addition, it has been widely reported that nuclear factor E2-related factor 2 (Nrf2)-antioxidant response element (ARE) pathway plays a central role in regulating antioxidant enzymes against oxidative stress [48,49]. Therefore, we speculate that CPs exerted their antioxidant effect in a direct and/or indirect manner. It is also possible that CPs exerted their beneficial effects on chronological aged skin in other ways, as previous studies have reported that Pro–Hyp in human blood after oral ingestion of CPs stimulates fibroblast growth [41,50]. It should be noted that proline intake did not have an obvious effect on skin antioxidant capacity. These results suggested that CPs had more complex action mechanisms underlying anti-aging effect than proline.
Bovine bone is an abundant source of gelatin. The CPs from bovine bone is mainly concentrated on its beneficial effect on bone metabolism. However, the current study found that the CPs from bovine bone also had beneficial effect on skin aging. The CPs prepared in this study mainly consist of oligopeptides (<1000 Da). It was reported that small peptides, especially the di-and tripeptides, are more easily absorbed in the intestinal tract than larger molecules, and oligopeptides are more bioactive than proteins, polypeptides and free amino acids [51,52]. Therefore, we speculated that ACP and CCP are readily absorbed and might exhibit potential biological effects once they are orally administered. Another purpose of this study is to preliminary investigate whether different CPs prepared by Alcalase and collagenase have different effects on chronologically aged skin. Based on the present results, it can be drawn that the beneficial effects of ACP were slightly better than those of CCP. Therefore, Alcalase is a favorable enzyme to produce CPs with beneficial effects on skin aging in food and medical industries. The present result of molecular weight distribution provides a guide for testing and controlling the quality of CPs. Besides, CPs should be protected from oxygen and light because of its easy oxidation.

5. Conclusions

In summary, the present study demonstrated oral administration of collagen peptides from bovine bone could improve the laxity of chronologically aged skin by increasing skin collagen content and ratio of type I to type III collagen, but it had no effect on moisture retention of skin. The beneficial effects of collagen peptides prepared by Alcalase (ACP) were slightly better than those of collagen peptides prepared by collagenase (CCP). Another action mechanism underlying the beneficial effects on aged skin of collagen peptides may be involved in increasing the antioxidant properties in the body. Proline intake also improved the laxity of chronologically aged skin but it did not affect the skin antioxidant capacity. These results suggest that collagen peptides from bovine bone and proline are potential dietary supplements for use against skin aging in chronologically aged process.

Acknowledgments

This study was supported by the earmarked fund from China Agriculture Research System (CARS-46) and National Natural Science Foundation of China (NSFC, No. 31271846).

Author Contributions

Bo Li conceived and designed the experiments; Hongdong Song, Siqi Zhang and Ling Zhang performed the experiments and analyzed the data; Hongdong Song and Bo Li wrote the paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Rittié, L.; Fisher, G.J. Natural and sun-induced aging of human skin. Cold Spring Harb. Perspect. Med. 2015, 5, a015370. [Google Scholar] [CrossRef] [PubMed]
  2. Durai, P.C.; Thappa, D.M.; Kumari, R.; Malathi, M. Aging in elderly: Chronological versus photoaging. Indian J. Dermatol. 2012, 57, 343–352. [Google Scholar] [PubMed]
  3. Helfrich, Y.R.; Sachs, D.L.; Voorhees, J.J. Overview of skin aging and photoaging. Dermatol. Nurs. 2008, 20, 177–183. [Google Scholar] [PubMed]
  4. Dobos, G.; Lichterfeld, A.; Blume-Peytavi, U.; Kottner, J. Evaluation of skin ageing: A systematic review of clinical scales. Brit. J. Dermatol. 2015, 172, 1249–1261. [Google Scholar] [CrossRef] [PubMed]
  5. Chen, J.; Li, Y.; Zhu, Q.; Li, T.; Lu, H.; Wei, N.; Huang, Y.; Shi, R.; Ma, X.; Wang, X.; et al. Anti-skin-aging effect of epigallocatechin gallate by regulating epidermal growth factor receptor pathway on aging mouse model induced by d-Galactose. Mech. Ageing Dev. 2017, 164, 1–7. [Google Scholar] [CrossRef] [PubMed]
  6. Tran, D.; Townley, J.P.; Barnes, T.M.; Greive, K.A. An antiaging skin care system containing alpha hydroxy acids and vitamins improves the biomechanical parameters of facial skin. Clin. Cosmet. Investig. Dermatol. 2015, 8, 9–17. [Google Scholar] [PubMed]
  7. Latreille, J.; Kesse-Guyot, E.; Malvy, D.; Andreeva, V.; Galan, P.; Tschachler, E.; Hercberg, S.; Guinot, C.; Ezzedine, K. Association between dietary intake of n-3 polyunsaturated fatty acids and severity of skin photoaging in a middle-aged Caucasian population. J. Dermatol. Sci. 2013, 72, 233–239. [Google Scholar] [CrossRef] [PubMed]
  8. Fanian, F.; Mac-Mary, S.; Jeudy, A.; Lihoreau, T.; Messikh, R.; Ortonne, J.P.; Sainthillier, J.M.; Elkhyat, A.; Guichard, A.; Kenari, K.H.; et al. Efficacy of micronutrient supplementation on skin aging and seasonal variation: A randomized, placebo-controlled, double-blind study. Clin. Interv. Aging 2013, 8, 1527–1537. [Google Scholar] [CrossRef] [PubMed]
  9. Murata, M.; Satoh, T.; Wakabayashi, H.; Yamauchi, K.; Abe, F.; Nomura, Y. Oral administration of bovine lactoferrin attenuates ultraviolet B-induced skin photodamage in hairless mice. J. Dairy Sci. 2014, 97, 651–658. [Google Scholar] [CrossRef] [PubMed]
  10. Zhuang, Y.; Hou, H.; Zhao, X.; Zhang, Z.; Li, B. Effects of collagen and collagen hydrolysate from jellyfish (Rhopilema esculentum) on mice skin photoaging induced by UV irradiation. J. Food Sci. 2009, 74, H183–H188. [Google Scholar] [CrossRef] [PubMed]
  11. Zague, V. A new view concerning the effects of collagen hydrolysate intake on skin properties. Arch. Dermatol. Res. 2008, 300, 479–483. [Google Scholar] [CrossRef] [PubMed]
  12. Oesser, S.; Adam, M.; Babel, W.; Seifert, J. Oral administration of 14C labeled gelatin hydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL). J. Nutr. 1999, 129, 1891–1895. [Google Scholar] [PubMed]
  13. Fan, J.; Zhuang, Y.; Li, B. Effects of collagen and collagen hydrolysate from jellyfish umbrella on histological and immunity changes of mice photoaging. Nutrients 2013, 5, 223–233. [Google Scholar] [CrossRef] [PubMed]
  14. Hou, H.; Li, B.; Zhang, Z.; Xue, C.; Yu, G.; Wang, J.; Bao, Y.; Bu, L.; Sun, J.; Peng, Z. Moisture absorption and retention properties, and activity in alleviating skin photodamage of collagen polypeptide from marine fish skin. Food Chem. 2012, 135, 1432–1439. [Google Scholar] [CrossRef] [PubMed]
  15. Song, H.; Meng, M.; Cheng, X.; Li, B.; Wang, C. The effect of collagen hydrolysates from silver carp (Hypophthalmichthys molitrix) skin on UV-induced photoaging in mice: Molecular weight affects skin repair. Food Funct. 2017, 8, 1538–1546. [Google Scholar] [CrossRef] [PubMed]
  16. Proksch, E.; Segger, D.; Degwert, J.; Schunck, M.; Zague, V.; Oesser, S. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: A double-blind, placebo-controlled study. Skin Pharmacol. Physiol. 2014, 27, 47–55. [Google Scholar] [CrossRef] [PubMed]
  17. Schwartz, S.R.; Park, J. Ingestion of BioCell Collagen®, a novel hydrolyzed chicken sternal cartilage extract; enhanced blood microcirculation and reduced facial aging signs. Clin. Interv. Aging 2012, 7, 267–273. [Google Scholar] [PubMed]
  18. Nur, A.T.; Che, M.Y.; Rn, R.M.H.; Aina, M.A.; Amin, I. Use of principal component analysis for differentiation of gelatine sources based on polypeptide molecular weights. Food Chem. 2014, 151, 286–292. [Google Scholar]
  19. Ali, M.E.; Sultana, S.; Hamid, S.B.; Hossain, M.A.; Yehya, W.A.; Kader, M.A.; Bhargava, S.K. Gelatin controversies in food, pharmaceuticals and personal care products: Authentication methods, current status and future challenges. Crit. Rev. Food Sci. Nutr. 2016, 29, 1–17. [Google Scholar] [CrossRef] [PubMed]
  20. Liu, J.; Wang, Y.; Song, S.; Wang, X.; Qin, Y.; Si, S.; Guo, Y. Combined oral administration of bovine collagen peptides with calcium citrate inhibits bone loss in ovariectomized rats. PLoS ONE 2015, 10, e0135019. [Google Scholar] [CrossRef] [PubMed]
  21. Kumar, S.; Sugihara, F.; Suzuki, K.; Inoue, N.; Venkateswarathirukumara, S. A double-blind, placebo-controlled, randomised, clinical study on the effectiveness of collagen peptide on osteoarthritis. J. Sci. Food Agric. 2015, 95, 702–707. [Google Scholar] [CrossRef] [PubMed]
  22. Humiski, L.M.; Aluko, R.E. Physicochemical and bitterness properties of enzymatic pea protein hydrolysates. J. Food Sci. 2007, 72, S605–S611. [Google Scholar] [CrossRef] [PubMed]
  23. Liang, Q.; Ren, X.; Ma, H.; Li, S.; Xu, K.; Oladejo, A.O. Effect of low-frequency ultrasonic-assisted enzymolysis on the physicochemical and antioxidant properties of corn protein hydrolysates. J. Food Qual. 2017, 2017, 1–10. [Google Scholar] [CrossRef]
  24. Kanth, S.V.; Venba, R.; Madhan, B.; Chandrababu, N.K.; Sadulla, S. Studies on the influence of bacterial collagenase in leather dyeing. Dyes Pigment. 2008, 76, 338–347. [Google Scholar] [CrossRef]
  25. Cheng, F.Y.; Hsu, F.W.; Chang, H.S.; Lin, L.C.; Sakata, R. Effect of different acids on the extraction of pepsin-solubilised collagen containing melanin from silky fowl feet. Food Chem. 2009, 113, 563–567. [Google Scholar] [CrossRef]
  26. Zhang, X.D.; Wu, H.Y.; Wu, D.; Wang, Y.Y.; Chang, J.H.; Zhai, Z.B.; Meng, A.M.; Liu, P.X.; Zhang, L.A.; Fan, F.Y. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int. J. Nanomed. 2010, 5, 771–781. [Google Scholar] [CrossRef] [PubMed]
  27. Jenkins, G. Molecular mechanisms of skin ageing. Mech. Ageing Dev. 2002, 123, 801–810. [Google Scholar] [CrossRef]
  28. Chung, J.H.; Seo, J.Y.; Choi, H.R.; Lee, M.K.; Youn, C.S.; Rhie, G.; Cho, K.H.; Kim, K.H.; Park, K.C.; Eun, H.C. Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J. Investig. Dermatol. 2001, 117, 1218–1224. [Google Scholar] [CrossRef] [PubMed]
  29. Song, H.; Zhang, L.; Luo, Y.; Zhang, S.; Li, B. Effects of collagen peptides intake on skin ageing and platelet release in chronologically aged mice revealed by cytokine array analysis. J. Cell. Mol. Med. 2017. [Google Scholar] [CrossRef] [PubMed]
  30. Ohara, H.; Ito, K.; Iida, H.; Matsumoto, H. Improvement in the moisture content of the stratum corneum following 4 weeks of collagen hydrolysate ingestion. Nippon Shokuhin Kogaku Kaishi 2009, 56, 137–145. [Google Scholar] [CrossRef]
  31. Reagan-Shaw, S.; Nihal, M.; Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22, 659–661. [Google Scholar] [CrossRef] [PubMed]
  32. Quan, T.; Fisher, G.J. Role of age-associated alterations of the dermal extracellular matrix microenvironment in human skin aging: A mini-review. Gerontology 2015, 61, 427–434. [Google Scholar] [CrossRef] [PubMed]
  33. Tanaka, Y.; Nakayama, J. Upregulated expression of La ribonucleoprotein domain family member 6 and collagen type I gene following water-filtered broad-spectrum near-infrared irradiation in a 3-dimensional human epidermal tissue culture model as revealed by microarray analysis. Australas. J. Dermatol. 2017. [Google Scholar] [CrossRef] [PubMed]
  34. Sadick, N.S.; Harth, Y. A 12-week clinical and instrumental study evaluating the efficacy of a multisource radiofrequency home-use device for wrinkle reduction and improvement in skin tone, skin elasticity, and dermal collagen content. J. Cosmet. Laser Ther. 2016, 18, 422–427. [Google Scholar] [CrossRef] [PubMed]
  35. Demaria, M.; Desprez, P.Y.; Campisi, J.; Velarde, M.C. Cell autonomous and non-autonomous effects of senescent cells in the skin. J. Investig. Dermatol. 2015, 135, 1722–1726. [Google Scholar] [CrossRef] [PubMed]
  36. Zouboulis, C.C.; Boschnakow, A. Chronological and photoaging of the human sebaceous gland. Clin. Exp. Dermatol. 2001, 26, 600–607. [Google Scholar] [CrossRef] [PubMed]
  37. Varani, J.; Dame, M.K.; Rittie, L.; Fligiel, S.E.; Kang, S.; Fisher, G.J.; Voorhees, J.J. Decreased collagen production in chronologically aged skin: Roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am. J. Pathol. 2006, 168, 1861–1868. [Google Scholar] [CrossRef] [PubMed]
  38. Lovell, C.R.; Smolenski, K.A.; Duance, V.C.; Light, N.D.; Young, S.; Dyson, M. Type I and III collagen content and fibre distribution in normal human skin during ageing. Br. J. Dermatol. 1987, 117, 419–428. [Google Scholar] [CrossRef] [PubMed]
  39. Papakonstantinou, E.; Roth, M.; Karakiulakis, G. Hyaluronic acid: A key molecule in skin aging. Dermato-Endocrinology 2012, 4, 253–258. [Google Scholar] [CrossRef] [PubMed]
  40. Haratake, A.; Watase, D.; Fujita, T.; Setoguchi, S.; Matsunaga, K.; Takata, J. Effects of oral administration of collagen peptides on skin collagen content and its underlying mechanism using a newly developed low collagen skin mice model. J. Funct. Foods 2015, 16, 174–182. [Google Scholar] [CrossRef]
  41. Ohara, H.; Ichikawa, S.; Matsumoto, H.; Akiyama, M.; Fujimoto, N.; Kobayashi, T.; Tajima, S. Collagen-derived dipeptide, proline-hydroxyproline, stimulates cell proliferation and hyaluronic acid synthesis in cultured human dermal fibroblasts. J. Dermatol. 2010, 37, 330–338. [Google Scholar] [CrossRef] [PubMed]
  42. Watanabe-Kamiyama, M.; Shimizu, M.; Kamiyama, S.; Taguchi, Y.; Sone, H.; Morimatsu, F.; Shirakawa, H.; Furukawa, Y.; Komai, M. Absorption and effectiveness of orally administered low molecular weight collagen hydrolysate in rats. J. Agric. Food Chem. 2010, 58, 835–841. [Google Scholar] [CrossRef] [PubMed]
  43. Callaghan, T.M.; Wilhelm, K.P. A review of ageing and an examination of clinical methods in the assessment of ageing skin. Part I: Cellular and molecular perspectives of skin ageing. Int. J. Cosmet. Sci. 2008, 30, 313–322. [Google Scholar] [CrossRef] [PubMed]
  44. Kammeyer, A.; Luiten, R.M. Oxidation events and skin aging. Ageing Res. Rev. 2015, 21, 16–29. [Google Scholar] [CrossRef] [PubMed]
  45. Xu, Y.; Fisher, G.J. Ultraviolet (UV) light irradiation induced signal transduction in skin photoaging. J. Dermatol. Sci. 2015, 1, S1–S8. [Google Scholar] [CrossRef]
  46. Liang, J.; Pei, X.; Zhang, Z.; Wang, N.; Wang, J.; Li, Y. The protective effects of long-term oral administration of marine collagen hydrolysate from chum salmon on collagen matrix homeostasis in the chronological aged skin of sprague-dawley male rats. J. Food Sci. 2010, 75, H230–H238. [Google Scholar] [CrossRef] [PubMed]
  47. Zague, V.; de Freitas, V.; Rosa, M.D.C.; de Castro, G.Á.; Jaeger, R.G.; Machado-Santelli, G.M. Collagen hydrolysate intake increases skin collagen expression and suppresses matrix metalloproteinase 2 activity. J. Med. Food 2011, 14, 618–624. [Google Scholar] [CrossRef] [PubMed]
  48. Maltese, G.; Psefteli, P.; Rizzo, B.; Srivastava, S.; Gnudi, L.; Mann, G.E.; Siow, R.C. The anti-ageing hormone klotho induces Nrf2-mediated antioxidant defences in human aortic smooth muscle cells. J. Cell. Mol. Med. 2017, 21, 621–627. [Google Scholar] [CrossRef] [PubMed]
  49. Sun, Z.; Park, S.Y.; Hwang, E.; Zhang, M.; Seo, S.A.; Lin, P.; Yi, T.H. Thymus vulgaris alleviates UVB irradiation induced skin damage via inhibition of MAPK/AP-1 and activation of Nrf2-ARE antioxidant system. J. Cell. Mol. Med. 2017, 21, 336–348. [Google Scholar] [CrossRef] [PubMed]
  50. Shigemura, Y.; Iwai, K.; Morimatsu, F.; Iwamoto, T.; Mori, T.; Oda, C.; Taira, T.; Park, E.Y.; Nakamura, Y.; Sato, K. Effect of Prolyl-hydroxyproline (Pro-Hyp), a food-derived collagen peptide in human blood, on growth of fibroblasts from mouse skin. J. Agric. Food Chem. 2009, 57, 444–449. [Google Scholar] [CrossRef] [PubMed]
  51. Bouglé, D.; Bouhallab, S. Dietary bioactive peptides: Human studies. Crit. Rev. Food Sci. Nutr. 2017, 57, 335–343. [Google Scholar] [CrossRef] [PubMed]
  52. Jia, J.; Zhou, Y.; Lu, J.; Chen, A.; Li, Y.; Zheng, G. Enzymatic hydrolysis of Alaska pollack (Theragra chalcogramma) skin and antioxidant activity of the resulting hydrolysate. J. Sci. Food Agric. 2010, 90, 635–640. [Google Scholar] [CrossRef] [PubMed]
Nutrients 09 01209 g001 550
Figure 1. The molecular weight distributions of collagen peptides.
Figure 1. The molecular weight distributions of collagen peptides.
Nutrients 09 01209 g001
Nutrients 09 01209 g002 550
Figure 2. Representative images of haematoxylin–eosin (HE)-stained dorsal skin section from all groups, Y, young group; M, model group (old group); ACP, administrated by collagen peptides which was prepared by Alcalase; CCP, administrated by collagen peptides which was prepared by collagenase; Pro, proline group. 200, 400 and 800 represent administration doses of 200, 400 and 800 mg/kg body weight, respectively. Sebaceous glands and space in dermis tissue are shown as red arrows and green arrows, respectively. Scale bars, 100 μm.
Figure 2. Representative images of haematoxylin–eosin (HE)-stained dorsal skin section from all groups, Y, young group; M, model group (old group); ACP, administrated by collagen peptides which was prepared by Alcalase; CCP, administrated by collagen peptides which was prepared by collagenase; Pro, proline group. 200, 400 and 800 represent administration doses of 200, 400 and 800 mg/kg body weight, respectively. Sebaceous glands and space in dermis tissue are shown as red arrows and green arrows, respectively. Scale bars, 100 μm.
Nutrients 09 01209 g002
Nutrients 09 01209 g003 550
Figure 3. Moisture content (A), hyaluronic acid content (B), hydroxyproline content (C) and ratio of type I to type III collagen (D) of chronologically aged mice after the administration of collagen peptides for 8 weeks. Y, young group; M, model group (old group); ACP, administrated by collagen peptides which was prepared by Alcalase; CCP, administrated by collagen peptides which was prepared by collagenase; Pro, proline group. 200, 400 and 800 represent administration doses of 200, 400 and 800 mg/kg body weight, respectively. The values are shown as the means ± SDs (n = 10 mice/group). A significant difference was observed at * p < 0.05 compared to the time-matched model group.
Figure 3. Moisture content (A), hyaluronic acid content (B), hydroxyproline content (C) and ratio of type I to type III collagen (D) of chronologically aged mice after the administration of collagen peptides for 8 weeks. Y, young group; M, model group (old group); ACP, administrated by collagen peptides which was prepared by Alcalase; CCP, administrated by collagen peptides which was prepared by collagenase; Pro, proline group. 200, 400 and 800 represent administration doses of 200, 400 and 800 mg/kg body weight, respectively. The values are shown as the means ± SDs (n = 10 mice/group). A significant difference was observed at * p < 0.05 compared to the time-matched model group.
Nutrients 09 01209 g003
Table
Table 1. Amino acid compositions of collagen peptides.
Table 1. Amino acid compositions of collagen peptides.
Amino AcidRelative Content (g/100 g) a,b
ACPCCP
Asp5.685.17
Glu10.5111.53
Ser3.383.17
Gly19.8421.28
His3.272.97
Thr7.908.51
Ala4.094.68
Pro12.4712.18
Arg8.618.47
Tyr2.281.79
Val3.062.90
Met1.791.27
Cys2.392.08
Ile4.113.93
Leu0.700.08
Phe9.319.36
Lys0.610.62
Total100.00100.00
a Expressed as g/100 g total amino acids; b ACP, collagen peptides prepared by Alcalase; CCP, collagen peptides prepared by collagenase.
Table
Table 2. Degree of skin laxity (DSL) of chronologically aged mice after the administration of collagen peptides for 8 weeks.
Table 2. Degree of skin laxity (DSL) of chronologically aged mice after the administration of collagen peptides for 8 weeks.
Group aDegree of Skin Laxity (DSL, mm)
Week 0Week 2Week 4Week 6Week 8
Y14.90 ± 2.32 *19.15 ± 1.57 *19.75 ± 1.03 *19.60 ± 0.91 *20.40 ± 1.48 *
M22.25 ± 2.40 22.40 ± 1.67 23.80 ± 2.25 22.50 ± 1.30 23.00 ± 1.26
ACP-20023.05 ± 0.56 23.50 ± 1.64 23.11 ± 1.26 22.00 ± 1.31 21.22 ± 1.47 *
ACP-40022.45 ± 1.88 21.55 ± 1.78 21.65 ± 1.5720.15 ± 1.34 * 20.25 ± 1.47 *
ACP-80022.30 ± 1.81 22.72 ± 2.06 22.05 ± 2.26 21.60 ± 1.78 19.80 ± 0.90 *
CCP-40022.40 ± 1.57 22.35 ± 1.41 21.25 ± 2.03 22.10 ± 1.92 19.95 ± 1.65 *
Pro-40021.65 ± 1.23 21.30 ± 2.28 22.80 ± 0.81 21.70 ± 1.00 19.75 ± 1.44 *
a Y, young group; M, model group (old group); ACP, administrated by collagen peptides which was prepared by Alcalase; CCP, administrated by collagen peptides which was prepared by collagenase; Pro, proline group. 200, 400 and 800 represent administration doses of 200, 400 and 800 mg/kg body weight, respectively. The values are shown as the means ± SDs (n = 10 mice/group). A significant difference was observed at * p < 0.05 compared to the time-matched model group.
Table
Table 3. Body weight, spleen index (SI) and thymus index (TI) of chronologically aged mice after the administration of collagen peptides for 8 weeks.
Table 3. Body weight, spleen index (SI) and thymus index (TI) of chronologically aged mice after the administration of collagen peptides for 8 weeks.
Group aBody Weight (g)Spleen Index b (mg/g)Thymus Index b (mg/g)
Week 0Week 2Week 4Week 6Week 8
Y28.28 ± 0.7330.27 ± 1.6231.71 ± 1.3032.63 ± 1.8132.70 ± 1.523.48 ± 0.691.82 ± 0.39
M47.14 ± 5.3945.55 ± 4.6745.55 ± 4.6946.52 ± 3.4046.33 ± 3.813.83 ± 1.141.55 ± 0.53
ACP-20047.41 ± 5.4746.28 ± 6.0746.44 ± 4.4147.41 ± 4.1346.83 ± 3.343.72 ± 0.061.71 ± 0.65
ACP-40047.50 ± 5.5746.32 ± 4.9146.90 ± 4.4846.64 ± 4.9046.35 ± 4.903.24 ± 1.242.06 ± 0.80
ACP-80047.75 ± 5.6746.88 ± 4.6848.36 ± 7.4249.40 ± 6.6347.39 ± 6.573.86 ± 1.391.55 ± 0.62
CCP-40047.92 ± 5.7346.82 ± 4.6148.13 ± 6.5548.84 ± 4.8847.38 ± 4.943.87 ± 0.941.62 ± 0.66
Pro-40047.24 ± 5.3946.96 ± 6.1446.32 ± 5.8647.65 ± 5.9047.44 ± 5.693.64 ± 1.042.02 ± 0.86
a Y, young group; M, model group (old group); ACP, administrated by collagen peptides which was prepared by Alcalase; CCP, administrated by collagen peptides which was prepared by collagenase; Pro, proline group. 200, 400 and 800 represent administration doses of 200, 400 and 800 mg/kg body weight, respectively. The values are shown as the means ± SDs (n = 10 mice/group). No significant difference between each administration group and time-matched model group was observed (p > 0.05). b Indicates values at week 8.
Table
Table 4. SOD and CAT activities and MDA content in dorsal skin of chronologically aged mice after administration of collagen peptides for 8 weeks.
Table 4. SOD and CAT activities and MDA content in dorsal skin of chronologically aged mice after administration of collagen peptides for 8 weeks.
Group aSOD (U/mg Protein)CAT (U/mg Protein)MDA Equivalents (nmol/mg Protein)
Y36.594 ± 1.142 *10.412 ± 1.143 *2.209 ± 0.278 *
M26.877 ± 3.8804.650 ± 1.5823.135 ± 0.302
ACP-20038.746 ± 0.753 *8.324 ± 0.890 *2.347 ± 0.209 *
ACP-40039.823 ± 3.410 *11.327 ± 1.096 *2.261 ± 0.107 *
ACP-80040.036 ± 4.820 *12.012 ± 0.752 *2.154 ± 0.325 *
CCP-40039.796 ± 1.211 *9.354 ± 1.856 *2.204 ± 0.201 *
Pro-40032.646 ± 1.6913.318 ± 0.6652.456 ± 0.316
a Y, young group; M, model group (old group); ACP, administrated by collagen peptides which was prepared by Alcalase; CCP, administrated by collagen peptides which was prepared by collagenase.; Pro, proline group. 200, 400 and 800 represent administration doses of 200, 400 and 800 mg/kg body weight, respectively. The values are shown as the means ± SDs (n = 10 mice/group). A significant difference was observed at * p < 0.05 compared to the time-matched model group.
Back to TopTop